Persistent URL of this record https://hdl.handle.net/1887/117375
Documents
-
- Download
- Gut_2014_63_1424
- Not Applicable (or Unknown)
- open access
In Collections
This item can be found in the following collections:
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation
- All authors
- Bodegraven, A.A. van; Bravenboer, N.; Witte, B.I.; Dijkstra, G.; Woude, C.J. van der; Stokkers, P.C.M.; Russel, M.G.; Oldenburg, B.; Pierik, M.; Roos, J.C.; Hogezand, R.A. van; Dik, V.K.; Oostlander, A.E.; Netelenbos, J.C.; Langerijt, L. van de; Hommes, D.W.; Lips, P.; Dutch Initiative Crohn Colitis ICC
- Date
- 2014-09-30
- Journal
- Gut
- Volume
- 63
- Issue
- 9
- Pages
- 1424 - 1430